| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 24.153 | 53.948 | 60.625 | 51.748 | 30.108 | 34.156 | 40.600 | 43.233 |
| Total Income - EUR | - | - | 24.153 | 53.948 | 60.625 | 51.755 | 30.115 | 34.156 | 40.600 | 45.697 |
| Total Expenses - EUR | - | - | 4.341 | 12.685 | 13.774 | 16.231 | 15.103 | 17.188 | 23.663 | 27.356 |
| Gross Profit/Loss - EUR | - | - | 19.812 | 41.263 | 46.852 | 35.524 | 15.012 | 16.968 | 16.937 | 18.341 |
| Net Profit/Loss - EUR | - | - | 19.571 | 40.723 | 46.245 | 35.048 | 14.717 | 16.633 | 16.539 | 17.917 |
| Employees | - | - | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Pharma Marketing Solutions Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 667 | 416 | 245 | 9.782 | 6.736 | 4.154 | 1.657 | 855 |
| Current Assets | - | - | 19.106 | 40.498 | 46.220 | 32.809 | 14.364 | 17.381 | 25.727 | 21.082 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 0 | 32.864 | 24.416 | 30.073 | 12.461 | 11.959 | 24.605 | 15.007 |
| Cash | - | - | 19.106 | 7.634 | 21.803 | 2.736 | 1.903 | 5.422 | 1.121 | 6.075 |
| Shareholders Funds | - | - | 19.615 | 40.766 | 46.296 | 35.118 | 14.790 | 16.706 | 16.612 | 17.989 |
| Social Capital | - | - | 44 | 43 | 42 | 62 | 61 | 61 | 61 | 60 |
| Debts | - | - | 158 | 148 | 169 | 7.722 | 6.433 | 5.047 | 11.097 | 4.036 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7320 - 7320" | |||||||||
| CAEN Financial Year |
7320
|
|||||||||
Comments - Pharma Marketing Solutions Srl